Zai Lab (ZLABN) Ratios
Zai Lab Ratios
MX:ZLABN's free cash flow for Q2 2026 was $-64.87M. For the 2026 fiscal year, MX:ZLABN's free cash flow was decreased by $-1.46M and operating cash flow was $-63.41M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.45 | 3.51 | 4.63 | 8.04 | 7.78 |
| Quick Ratio | 2.27 | 3.38 | 4.41 | 7.81 | 7.68 |
| Cash Ratio | 1.63 | 1.50 | 3.89 | 7.21 | 5.00 |
| Solvency Ratio | -0.35 | -0.69 | -1.36 | -2.49 | -3.03 |
| Operating Cash Flow Ratio | -0.36 | -0.72 | -0.98 | -2.63 | -2.85 |
| Short-Term Operating Cash Flow Coverage | -0.74 | -1.63 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 562.40M | $ 705.63M | $ 699.43M | $ 949.79M | $ 1.27B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.19 | 0.13 | 0.01 | 0.02 | 0.01 |
| Debt-to-Equity Ratio | 0.31 | 0.18 | 0.02 | 0.02 | 0.01 |
| Debt-to-Capital Ratio | 0.24 | 0.15 | 0.02 | 0.02 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.64 | 1.41 | 1.30 | 1.17 | 1.17 |
| Debt Service Coverage Ratio | -0.74 | -1.75 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | -42.92 | -125.16 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.11 | 0.05 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.10 | 1.57 | 1.57 | 2.13 | 1.67 |
| Net Debt to EBITDA | 2.88 | 1.26 | 2.12 | 2.27 | 1.38 |
| Profitability Margins | |||||
| Gross Profit Margin | 58.47% | 62.94% | 64.08% | 65.58% | 63.80% |
| EBIT Margin | -37.65% | -63.87% | -140.27% | -206.04% | -482.25% |
| EBITDA Margin | -34.39% | -58.79% | -136.89% | -202.21% | -477.76% |
| Operating Profit Margin | -48.59% | -70.71% | -137.44% | -188.04% | -485.10% |
| Pretax Profit Margin | -38.78% | -64.44% | -125.46% | -206.14% | -487.43% |
| Net Profit Margin | -38.15% | -64.44% | -125.46% | -206.14% | -488.16% |
| Continuous Operations Profit Margin | -38.15% | -64.44% | -125.46% | -206.14% | -488.16% |
| Net Income Per EBT | 98.36% | 100.00% | 100.00% | 100.00% | 100.15% |
| EBT Per EBIT | 79.82% | 91.13% | 91.28% | 109.63% | 100.48% |
| Return on Assets (ROA) | -14.97% | -21.68% | -32.29% | -36.33% | -43.76% |
| Return on Equity (ROE) | -24.53% | -30.57% | -42.03% | -42.40% | -51.05% |
| Return on Capital Employed (ROCE) | -29.56% | -31.83% | -43.99% | -37.43% | -49.40% |
| Return on Invested Capital (ROIC) | -22.74% | -27.49% | -43.62% | -37.19% | -49.20% |
| Return on Tangible Assets | -16.01% | -22.82% | -32.81% | -36.58% | -44.02% |
| Earnings Yield | -9.09% | -9.92% | -126.69% | -150.71% | -120.53% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.34 | 4.46 | 4.08 | 4.43 | 2.63 |
| Payables Turnover | 1.35 | 1.47 | 0.85 | 1.12 | 0.41 |
| Inventory Turnover | 2.56 | 3.71 | 2.14 | 2.34 | 2.76 |
| Fixed Asset Turnover | 6.92 | 5.74 | 3.88 | 2.73 | 2.48 |
| Asset Turnover | 0.39 | 0.34 | 0.26 | 0.18 | 0.09 |
| Working Capital Turnover Ratio | 0.68 | 0.54 | 0.31 | 0.19 | 0.12 |
| Cash Conversion Cycle | -43.55 | -68.86 | -170.26 | -86.96 | -610.48 |
| Days of Sales Outstanding | 84.17 | 81.79 | 89.41 | 82.44 | 138.63 |
| Days of Inventory Outstanding | 142.78 | 98.43 | 170.76 | 155.93 | 132.41 |
| Days of Payables Outstanding | 270.50 | 249.09 | 430.43 | 325.33 | 881.52 |
| Operating Cycle | 226.95 | 180.23 | 260.17 | 238.37 | 271.04 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.38 | -2.17 | -20.51 | -38.37 | -59.06 |
| Free Cash Flow Per Share | -1.50 | -2.79 | -21.39 | -40.98 | -61.10 |
| Dividend Paid and CapEx Coverage Ratio | -11.23 | -3.49 | -23.34 | -14.72 | -28.99 |
| Capital Expenditure Coverage Ratio | -11.23 | -3.49 | -23.34 | -14.72 | -28.99 |
| Operating Cash Flow Coverage Ratio | -0.67 | -1.40 | -13.08 | -18.03 | -35.34 |
| Operating Cash Flow to Sales Ratio | -0.33 | -0.54 | -0.74 | -1.71 | -3.81 |
| Free Cash Flow Yield | -8.50% | -10.67% | -78.25% | -133.49% | -97.22% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -11.03 | -10.07 | -0.79 | -0.66 | -0.83 |
| Price-to-Sales (P/S) Ratio | 4.20 | 6.50 | 0.99 | 1.37 | 4.05 |
| Price-to-Book (P/B) Ratio | 2.70 | 3.08 | 0.33 | 0.28 | 0.42 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -11.77 | -9.38 | -1.28 | -0.75 | -1.03 |
| Price-to-Operating Cash Flow Ratio | -12.81 | -12.06 | -1.33 | -0.80 | -1.06 |
| Price-to-Earnings Growth (PEG) Ratio | 0.29 | 0.11 | 0.03 | 0.02 | -0.01 |
| Enterprise Value Multiple | -9.33 | -9.78 | 1.40 | 1.60 | 0.53 |
| Enterprise Value | 1.48B | 2.30B | -510.88M | -693.95M | -364.10M |
| EV to EBITDA | -9.33 | -9.78 | 1.40 | 1.60 | 0.53 |
| EV to Sales | 3.21 | 5.75 | -1.92 | -3.23 | -2.52 |
| EV to Free Cash Flow | -8.99 | -8.30 | 2.47 | 1.77 | 0.64 |
| EV to Operating Cash Flow | -9.79 | -10.68 | 2.58 | 1.89 | 0.66 |
| Tangible Book Value Per Share | 5.84 | 7.90 | 80.68 | 108.26 | 147.36 |
| Shareholders’ Equity Per Share | 6.53 | 8.50 | 82.38 | 109.14 | 148.39 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | 0.00 | 0.00 | 0.00 | -0.00 |
| Revenue Per Share | 4.20 | 4.03 | 27.60 | 22.45 | 15.52 |
| Net Income Per Share | -1.60 | -2.60 | -34.63 | -46.27 | -75.76 |
| Tax Burden | 0.98 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.03 | 1.01 | 0.89 | 1.00 | 1.01 |
| Research & Development to Revenue | 0.48 | 0.59 | 1.00 | 1.33 | 3.97 |
| SG&A to Revenue | 0.60 | 0.75 | 1.06 | 0.92 | 1.52 |
| Stock-Based Compensation to Revenue | 0.14 | 0.18 | 0.30 | 0.29 | 0.28 |
| Income Quality | 0.86 | 0.84 | 0.59 | 0.83 | 0.78 |
Currency in USD